ETFs
P
PRME
Prime Medicine
3.935
+0.105+2.74%Opening13:01 10/20 EDT
OPEN/PREV CLOSE3.750/3.830
TODAY RANGE3.730-4.050
VOL1.86M
MARKET CAP713.72M
52 WEEK RANGE2.670-6.30
AVG VOL (3M)3.49M
% TURNOVER1.02%
TURNOVER--
P/E (TTM)-3.6101
% RANGE8.36%
EPS(TTM)-1.0900
P/E(FORWARD)-3.9825
P/B17.86
BVPS0.2203
DIVIDEND--
P/S153.11
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP568.78M
SHARES OUTSTANDING181.38M
NEXT EARNINGS11/05-11/09
FREE FLOAT144.54M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·10/11 15:54
Leading Indicators For The October Breakout Cycle
Benzinga·10/09 14:51
Humana, Evolution Metals & Technologies, Fastly And Other Big Stocks Moving Higher On Friday
Benzinga·10/07 17:05
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga·10/06 13:59
Apogee Enterprises Posts Upbeat Q2 Earnings, Joins Constellation Energy, Freshworks And Other Big Stocks Moving Higher On Tuesday
TipRanks·10/05 12:16
Prime Medicine doses first patient in PM577a trial
TipRanks·10/01 14:26
Prime Medicine, Inc. (PRME) Gets a Buy from H.C. Wainwright
Seeking Alpha·09/29 11:30
Beam Therapeutics: Ignore The Anthropic Noise And Focus On Clinical Progress
Seeking Alpha·09/25 20:00
Prime: A Buy Due To BLA Filing H1 '27 And Continued PM647 Advancement
Benzinga·09/25 17:56
Prime Medicine Gets FDA Green Light for Gene Editing Study
TipRanks·09/25 13:45
Oppenheimer Remains a Buy on Prime Medicine, Inc. (PRME)
Dow Jones·09/25 12:19
Prime Medicine Price Target Maintained With a $7.00/Share by Chardan Capital
Dow Jones·09/25 12:19
Prime Medicine Is Maintained at Buy by Chardan Capital
Seeking Alpha·09/25 10:45
At a glance: stocks gapping up premarket
Same Industry
Name/Symbol
Change%
Price